Cargando…

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey

BACKGROUND & AIMS: The World Health Organization (WHO) HBV and HCV elimination targets, set in 2016 and based on projections to 2030, were unable to consider the impact of intervening factors. To evaluate the impact of the COVID-19 pandemic on viral hepatitis elimination programs, the European A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kondili, Loreta A., Buti, Maria, Riveiro-Barciela, Mar, Maticic, Mojca, Negro, Francesco, Berg, Thomas, Craxì, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364666/ https://www.ncbi.nlm.nih.gov/pubmed/35967191 http://dx.doi.org/10.1016/j.jhepr.2022.100531

Ejemplares similares

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
por: Boettler, Tobias, et al.
Publicado: (2020)

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
por: Boettler, Tobias, et al.
Publicado: (2020)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
por: Mennini, Francesco S., et al.
Publicado: (2021)

Will the COVID-19 pandemic affect HCV disease burden?
por: Kondili, Loreta A., et al.
Publicado: (2020)

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
por: Roade, Luisa, et al.
Publicado: (2021)

Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study
por: Riveiro-Barciela, Mar, et al.
Publicado: (2021)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
por: Buti, Maria, et al.
Publicado: (2021)

An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
por: Riveiro-Barciela, Mar, et al.
Publicado: (2020)

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2022)

Thriving in turbulent times: EASL reflects on 2021, looking to 2022 and beyond
por: Berg, Thomas, et al.
Publicado: (2022)

Correction: Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2023)

A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia
por: Maticic, Mojca
Publicado: (2014)

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
por: Cornberg, Markus, et al.
Publicado: (2021)

Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions
por: Rosato, Valerio, et al.
Publicado: (2022)

Hepatitis B Elimination in Children of Slovenian Origin Born in Slovenia After the Introduction of Preventive Strategies: the Results of a National Study
por: Kmet, Nina Grasselli, et al.
Publicado: (2022)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
por: Marjot, Thomas, et al.
Publicado: (2022)

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
por: Álvarez-López, Patricia, et al.
Publicado: (2020)

Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS)
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

JHEP Reports: A new EASL open access journal
por: Zucman-Rossi, Jessica
Publicado: (2019)

Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries
por: Maticic, Mojca, et al.
Publicado: (2014)

Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain
por: Palom, Adriana, et al.
Publicado: (2023)

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The “HCV ICEberg” Project
por: Coppola, Carmine, et al.
Publicado: (2023)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
por: Palom, Adriana, et al.
Publicado: (2022)

Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection
por: Riveiro-Barciela, Mar, et al.
Publicado: (2014)

Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries
por: Maticic, Mojca, et al.
Publicado: (2019)

A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
por: Lazarus, Jeffrey V, et al.
Publicado: (2014)

Prisons: an important link in the elimination of Hepatitis B
por: Barreira-Díaz, A, et al.
Publicado: (2021)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
por: Roade, Luisa, et al.
Publicado: (2023)

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus
por: Caballero, Andrea, et al.
Publicado: (2015)

Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population
por: Casillas, Rosario, et al.
Publicado: (2018)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions
por: Kondili, Loreta A., et al.
Publicado: (2022)

HMAP, World Hepatitis Day and the bigger health systems picture
por: Lazarus, Jeffrey V., et al.
Publicado: (2016)

The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
por: Maticic, M., et al.
Publicado: (2020)

Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?
por: Kondili, Loreta A., et al.
Publicado: (2018)

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona
por: Barreira Díaz, Ana, et al.
Publicado: (2022)

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management
por: Grau-López, Lara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ps6q548rmub3bd8jf67q1u7s6